Jiangsu Sihuan Bioengineering Co., Ltd 000518

Overview

Jiangsu Sihuan Bioengineering Co., Ltd. is a prominent player in the pharmaceutical sector within China, recognized for its commitment to delivering innovative healthcare solutions since its inception in 1992. With its headquarters nestled in Jiangyin, China, the company has established itself as a formidable force in the development, production, and marketing of pharmaceutical products. Jiangsu Sihuan Bioengineering Co., Ltd. has expanded its horizons beyond its initial pharmaceutical endeavors to include activities in the agricultural sector, specifically focusing on the breeding and sales of flowers and seedlings, in addition to undertaking landscaping projects. This diversification underscores the company's versatility and its drive to explore different business avenues while maintaining its core focus on pharmaceutical advances.

Products and Services

The product lineup from Jiangsu Sihuan Bioengineering Co., Ltd. is marked by a blend of innovative pharmaceutical solutions and agricultural offerings:

• Delusen: This flagship biotherapeutic drug stands out as the crown jewel in Jiangsu Sihuan's pharmaceutical range, targeting several forms of cancer, including kidney cancer, malignant melanoma, and cancerous chest and abdominal masses. Delusen represents the company's stride towards pioneering in the field of oncology, showcasing its commitment to combatting formidable diseases with cutting-edge biotechnology.
• Xinde Lusheng: While the specific details of this product are not extensively described, its inclusion in the company's portfolio indicates Jiangsu Sihuan's dedication to broadening its pharmaceutical offerings, potentially addressing other critical areas of medical need.
• Xin Lisheng: Similarly, Xin Lisheng contributes to the depth of Jiangsu Sihuan's product range. Although its precise application is not detailed, it underscores the company's continuous effort to innovate and expand its footprint in the healthcare industry.
• Ring BO: Detailing of Ring BO's specific therapeutic use or composition is limited, but its listing among the company's products implies a varied approach to healthcare solutions, which may complement the therapeutic effects of the other drugs produced by Jiangsu Sihuan.
• Breeding and Sales of Flowers and Seedlings: Diversifying beyond the pharmaceutical realm, Jiangsu Sihuan also engages in horticulture. The company capitalizes on the breeding and sales of flowers and seedlings, venturing into the agricultural sector with a focus on aesthetic and environmental contributions through landscaping projects.
• Landscaping Projects: This service complements the agricultural aspect of the company, involving the planning, design, management, and nurturing of gardens and landscapes. These projects likely harness the company's expertise in botany, as suggested by its involvement in flower and seedling sales, to enhance communal, private, and public spaces.